Collaborations
 

• Retrotope collaborates with Prof. Andrey Abramov’s laboratory at the Institute of Neurology, University College London on studies of lipid peroxidation involvement in alpha-synuclein toxicity in Parkinson's disease.
   
• Retrotope collaborates with Prof. Yuri Antonenko at Moscow State University Moscow, Russia, on novel approaches to monitoring lipid peroxidation in lipid membranes.
   
• Retrotope collaborates with Prof. Paul Axelsen at the University of Pennsylvania School of Medicine, on studies pertaining to modified lipid distribution in vivo.
   
• Retrotope collaborates with Prof. M. Flint Beal (Weill Cornell Medical College, New York) on novel approaches to treatment of Parkinson’s disease.
   
• Retrotope collaborates with Prof. Brian Bennett at the Department of Biomedical and Molecular Sciences, Queen's University at Kingston, Canada, on novel approaches to alleviating the Alzheimer's phenotype in ALDH mouse models.
   
• Retrotope collaborates with Prof. Jimmy Berbee at the Leiden University Medical Center  on novel approaches to mitigating atherosclerosis.
   
• Retrotope collaborates with Dr. Valery Bochkov of the Karl-Franzens University of Graz, Austria, on the use of modified lipids to control enzymatic and non-enzymatic lipid oxidation products.
  .
• Retrotope collaborates with Prof. Tom Brenna’s laboratory at the Cornell university, Ithaca on studies of PUFA circulation and metabolism using isotope ratio MS techniques.
   
• Retrotope collaborates with Dr. Patrik Brundin’s laboratory at Van Andel Research Institute, Michigan, USA on novel approaches to curing Parkinson’s disease.
   
• Retrotope collaborates with Prof. Judy Campisi of the Buck Institute, California, USA on the novel approaches to mitigating the ROS effect on aging.
   
• Retrotope collaborates with Prof. Marie-Francoise Chesselet’s laboratory at the David Geffen School of Medicine, University of California, Los Angeles on studies of lipid peroxidation involvement in Huntington's disease.
   
• Retrotope collaborates with Prof. Catherine F. Clarke’s laboratory at the Department of Chemistry and Biochemistry, University of California, Los Angeles on studies of oxidative stress in different yeast models.
   
• Retrotope collaborates with Prof. Steven Clarke and Dr Jonathan Lowenson at the Department of Chemistry and Biochemistry, UCLA on novel approaches to controlling racemization of amino acids.
   
• Retrotope collaborates with Prof. Susan Cotman’s laboratory at Harvard Medical School on studies of lipid peroxidation involvement in neuronal ceroid lipofuscinosis (NCL, Batten disease).
   
• Retrotope collaborates with Prof Victor Darley-Usmar of the Department of Pathology, University of Alabama at Birmingham on cell culture studies of oxidative stress and lipid peroxidation in vascular tissues.
   
• Retrotope collaborates with Prof. Edward Dennis at the Departments of Chemistry & Biochemistry and Pharmacology at UCSD, San Diego on regulation of pro- and antiinflammatory responses in cell cultures.
   
• Retrotope collaborates with Dr. Thierry Durand and Dr Jean-Marie Galano at IBMM (Institut des Biomolecules Max Mousseron) in Montpellier, France on studies of PUFA-derived biomediators.
   
• Retrotope collaborates with Dr. Rafal Farjo, of EyeCRO, Oklahoma, on novel methods of delivering modified lipids to the eye.
   
• Retrotope collaborates with Prof. Werner Gellermann of at the University of Utah School of Medicine on novel analytical approaches to detecting modified lipids in vivo.
   
• Retrotope collaborates with Prof. Amato Giaccia of the Department of Radiation Oncology, Stanford University, on novel approaches to controlling covalent interactions in connective tissues.
   
• Retrotope collaborates with Dr. Paola Giunti at the Institute of Neurology, University College London on studies of lipid peroxidation involvement in Friedreich’s ataxia.
   
• Retrotope collaborates with Prof. Peter Grace at the University of Texas MD Anderson Cancer Center, Houston, Texas on studies pertaining to modulating various aspects of persistent/chronic pain with modified lipids.
   
• Retrotope collaborates with Prof. Richard Haas of the Rady Children’s Hospital at UCSD, San Diego on novel approaches to mitigating mitochondrial diseases.
   
• Retrotope collaborates with Prof. Kendall N. Houk, Department of Chemistry and Biochemistry, UCLA, USA on Density Functional Theory applications to the isotope effect studies.
   
• Retrotope collaborates with Prof. Valerian Kagan of the Department of Environmental and Occupational Health, University of Pittsburgh, on oxidative stress influence on function of lipid membranes.
   
• Retrotope collaborates with Priv.-Doz. Dr. med Tim Krohne at Bonn University Eye Clinic, Germany, on novel approaches to mitigating RPE mediated ocular pathologies.
   
• Retrotope collaborates with Professor Emeritus Fred A. Kummerow (born 1914) at the University of Illinois at Urbana-Champaign, USA on novel approaches to modulating oxidative stress at the cellular level.
   
• Retrotope collaborates with Dr. J. William Langston, MD, of the Parkinson's Institute and Clinical Center, Sunnyvale, California,  on novel approaches to treating Parkinson's disease.
   
• Retrotope collaborates with Prof. Charles Liberman, Massachusetts Eye and Ear and Harvard Medical School, on novel approaches to mitigating deafness.
   
• Retrotope collaborates with Prof. Mark Mattson’s Neurosciences laboratory at the National Institute on Aging at Baltimore on studies of lipid peroxidation involvement in Alzheimer's disease.
   
• Retrotope collaborates with Prof. Ginger Milne’s laboratory at the Medical Center, Vanderbilt University on studies of lipid peroxidation assessment using isoprostane measurements.
   
• Retrotope collaborates with Prof. Anne Murphy’s laboratory at the Department of Pharmacology, UCSD on studies of lipid peroxidation involvement in mitochondrial performance and bioenergetics.
   
• Retrotope collaborates with Dr. Mike Murphy of the MRC Mitochondrial Biology Unit, Cambridge, UK on various aspects of mitochondrial lipid peroxidation.

• Retrotope collaborates with Dr Anne Negre-Salvayre, Institute of Cardiovascular and Metabolic Diseases, Toulouse, France on issues related to toxicity of lipid peroxidation products in various models.

• Retrotope collaborates with Dr. Elizabeth New at the University of Sydney, Australia on novel approaches to modulating the redox status of mitochondria.

• Retrotope collaborates with Prof. Thomas Nyström at the laboratory of Aging and protein quality control, University of Gothenburg, Sweden on novel approaches to controlling ageing of yeast.
  .
• Retrotope collaborates with Dr. Nikolai Pestov of the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, on the in vivo effects of modified essential nutrients.
   
• Retrotope collaborates with Prof. Elena Pohl at the University of Veterinary Medicine, Vienna, Austria on novel approaches to preserving the conductance of lipid membranes.
   
• Retrotope collaborates with Dr. Erik Pollock at the University of Arkansas Stable Isotope Laboratory on analytical biochemistry studies of D-PUFA distribution.
   
• Retrotope collaborates with Prof. Mark Pook’s laboratory at Brunel University, London on studies of novel approaches to mitigating Friedreich's ataxia.
   
• Retrotope collaborates with Prof. Ned A. Porter’s laboratory at the Department of Chemistry, Vanderbilt University on in vitro studies of deuterated PUFA peroxidation.

• Retrotope collaborates with Prof. Derek Pratt, Department of Chemistry and Biomolecular Sciences, University of Ottawa, Canada on enzymatic aspects of lipid peroxidation.

• Retrotope collaborates with Prof. Aurora Pujol’s Neurometabolic Diseases Laboratory at the Institut D’Investigacio Biomedica De Bellvitge, Barcelona, Spain on novel approaches to mitigating X-adrenoleukodystrophy (ALD).

• Retrotope collaborates with Prof. Norbert Reich at the Department of Chemistry and Biochemistry, UCSB on novel approaches to controlling DNA methylation.
   
• Retrotope collaborates with Prof. Marina Sergeeva at Moscow State University Moscow, Russia, on novel approaches to controlling the pro- and antiinflammatory product formation by COX, LOX and Cyt groups of enzymes.
   
• Retrotope collaborates collaborates with Prof. Charles Serhan, Department of Biological Chemistry and Molecular Pharmacology, Harvard University, on novel approaches to controlling the formation of PUFA-derived signalling molecules
   
• Retrotope collaborates with Prof. David T. Shima’s laboratory at the Institute of Ophthalmology, University College London on studies of oxidative stress in retinal disease models.
   
• Retrotope collaborates with the laboratory of Dr. Vadim V. Shmanai at the Institute of Physical Organic Chemistry of National Academy of Sciences of Belarus in Minsk on the chemical aspects of deuteration of lipids, amino acids and nucleosides.
   
• Retrotope collaborates with Prof. Janet Sparrow at the Department of Pathology and Cell Biology, Columbia University, New York on novel approaches to mitigating Age related Macular Degeneration.
   
• Retrotope collaborates with Prof. Brent Stockwell at the Howard Huges Medical Institute, Columbia University, New York on novel approaches to controlling cell death.
   
• Retrotope collaborates with Prof. Randy Strong at the School of Medicine, UT Health Science Center, San Antonio, Texas, on novel approaches to alleviating the Parkinson's phenotype in ALDH mouse models.
   
• Retrotope collaborates with Prof. Irina Udalova of the Kennedy Institute of Rheumatology, Oxford University, UK, on the modulation of various aspects of the immune system signalling with modified lipids in various models.
   
• Retrotope collaborates with Prof. Dragoslav Vidovic at the Nanyang Technological University, Singapore on novel synthetic approaches to PUFA derivatives.
   
• Retrotope collaborates with Prof. Jan Vijg at the Albert Einstein College of Medicine, New York on longevity studies in mouse models.
   
• Retrotope collaborates with Prof. Robert B. Wilson's laboratory at the Institute of Translational Medicine and Therapeutics, University of Pennsylvania, on the development of novel therapeutics for Friedreich's ataxia.
   
• Retrotope collaborates with Dr. Theresa Zesiewicz of the University of South Florida Ataxia Research Center, USA on the clinical trials of Retrotope’s RT001.